Hepatic dysfunction and survival after orthotopic heart transplantation: Application of the MELD scoring system for outcome prediction

被引:132
作者
Chokshi, Aalap [1 ]
Cheema, Faisal H. [2 ]
Schaefle, Kenneth J. [2 ]
Jiang, Jeffrey [2 ]
Collado, Elias [1 ]
Shahzad, Khurram [1 ]
Khawaja, Tuba [1 ]
Farr, Maryjane [1 ]
Takayama, Hiroo [2 ]
Naka, Yoshifumi [1 ]
Mancini, Donna M. [1 ]
Schulze, P. Christian [1 ]
机构
[1] Columbia Univ, New York Presbyterian Hosp, Med Ctr, Div Cardiol,Dept Med, New York, NY 10032 USA
[2] Columbia Univ, Div Cardiothorac Surg, Med Ctr, Dept Surg, New York, NY 10032 USA
关键词
heart failure; liver dysfunction; MELD; heart transplantation; outcomes; STAGE LIVER-DISEASE; FUNCTION ABNORMALITIES; FAILURE; MODEL; MORTALITY; CIRRHOSIS; SURGERY;
D O I
10.1016/j.healun.2012.02.008
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BACKGROUND: The prevalence of heart failure (HF) is rising and the only corrective treatment is cardiac transplantation. Advanced HF is associated with congestive hepatopathy and progressive functional and ultrastructural changes of the liver. We hypothesized that hepatic dysfunction is associated with impaired clinical outcome after heart transplantation. METHODS: Data of 617 adult patients (75% men, mean age 53 +/- 12 years, mean BMI 25 +/- 4, mean ejection fraction 19 +/- 9%) undergoing orthotopic heart transplantation (OHT) were analyzed retrospectively. Deviation from institutional normal ranges was used to define abnormal liver function. Standard Model for End-stage Liver Disease (MELD) scores were calculated and a modified MELD score with albumin replacing INR (modMELD) was created to eliminate the confounding effects of anti-coagulation. RESULTS: Before OHT, AST, ALT and total bilirubin were elevated in 20%, 18% and 29% of the population, respectively. Total protein and albumin were decreased in 25% and 52% of the population, respectively. By 2 months post-transplantation, percentages of individuals with pathologic values decreased significantly, except for ALT, total protein and albumin, all of which took longer to normalize. Individuals with a higher pre-transplantation MELD or modMELD score had worse outcome 30 days post-transplant and reduced long-term survival over a 10-year follow-up. CONCLUSIONS: In this large, single-center retrospective study, we demonstrated the dynamics of liver dysfunction after cardiac transplantation and that elevated MELD scores indicating impaired liver function are associated with poor clinical outcome after OHT. Thus, pre-operative liver dysfunction has a significant impact on survival of patients after cardiac transplantation. J Heart Lung Transplant 2012;31:591-600 (C) 2012 International Society for Heart and Lung Transplantation. All rights reserved.
引用
收藏
页码:591 / 600
页数:10
相关论文
共 20 条
[1]   Model for End-Stage Liver Disease Predicts Mortality for Tricuspid Valve Surgery [J].
Ailawadi, Gorav ;
LaPar, Damien J. ;
Swenson, Brian R. ;
Siefert, Suzanne A. ;
Lau, Christine ;
Kern, John A. ;
Peeler, Benjamin B. ;
Littlewood, Keith E. ;
Kron, Irving L. .
ANNALS OF THORACIC SURGERY, 2009, 87 (05) :1460-1468
[2]   Liver function abnormalities and outcome in patients with chronic heart failure: data from the Candesartan in Heart Failure: Assessment of Reduction in Mortality and Morbidity (CHARM) program [J].
Allen, Larry A. ;
Felker, G. Michael ;
Pocock, Stuart ;
McMurray, John J. V. ;
Pfeffer, Marc A. ;
Swedberg, Karl ;
Wang, Duolao ;
Yusuf, Salim ;
Michelson, Eric L. ;
Granger, Christopher B. .
EUROPEAN JOURNAL OF HEART FAILURE, 2009, 11 (02) :170-177
[3]   Liver dysfunction and heart failure [J].
Cogger, VC ;
Fraser, R ;
Le Couteur, DG .
AMERICAN JOURNAL OF CARDIOLOGY, 2003, 91 (11) :1399-1399
[4]   Cardiac hepatopathy before and after heart transplantation [J].
Dichtl, W ;
Vogel, W ;
Dunst, KM ;
Grander, W ;
Alber, HF ;
Frick, M ;
Antretter, H ;
Laufer, G ;
Pachinger, O ;
Pölzl, G .
TRANSPLANT INTERNATIONAL, 2005, 18 (06) :697-702
[5]  
Hayashida Nobuhiko, 2004, Ann Thorac Cardiovasc Surg, V10, P140
[6]   Heart transplantation in patients with liver cirrhosis [J].
Hsu, Ron-Bin ;
Chang, Chung-I ;
Lin, Fang-Yue ;
Chou, Nai-Kuan ;
Chi, Nai-Hsin ;
Wang, Shoei-Shen ;
Chu, Shu-Hsun .
EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY, 2008, 34 (02) :307-312
[7]   A model to predict survival in patients with end-stage liver disease [J].
Kamath, PS ;
Wiesner, RH ;
Malinchoc, M ;
Kremers, W ;
Therneau, TM ;
Kosberg, CL ;
D'Amico, G ;
Dickson, ER ;
Kim, WR .
HEPATOLOGY, 2001, 33 (02) :464-470
[8]   LIVER-FUNCTION ABNORMALITIES IN CHRONIC HEART-FAILURE - INFLUENCE OF SYSTEMIC HEMODYNAMICS [J].
KUBO, SH ;
WALTER, BA ;
JOHN, DHA ;
CODY, RJ .
ARCHIVES OF INTERNAL MEDICINE, 1987, 147 (07) :1227-1230
[9]   Type of liver dysfunction in heart failure and its relation to the severity of tricuspid regurgitation [J].
Lau, GT ;
Tan, HC ;
Kritharides, L .
AMERICAN JOURNAL OF CARDIOLOGY, 2002, 90 (12) :1405-+
[10]   Heart diseases affecting the liver and liver diseases affecting the heart [J].
Naschitz, JE ;
Slobodin, G ;
Lewis, RJ ;
Zuckerman, E ;
Yeshurun, D .
AMERICAN HEART JOURNAL, 2000, 140 (01) :111-+